financetom
Business
financetom
/
Business
/
Why Azitra Stock Is Crashing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Azitra Stock Is Crashing
Jul 24, 2024 10:07 AM

Azitra Inc. ( AZTR ) shares are crashing Wednesday after the company announced the pricing of a $10 million public offering of 6,665,000 common shares and Class A warrants at $1.50 per share.

The Details:

Azitra ( AZTR ) shares spiked Tuesday after the company announced that the U.S. Patent and Trademark Office (USPTO) had granted the company a patent covering future potential pipeline candidates for indications including atopic dermatitis, titled “Therapeutic treatment of skin disease with recombinant skin microorganisms.”

Read Next: What’s Going On With Carnival Stock?

Azitra ( AZTR ) announced the pricing of its $10 million public offering after the market close Tuesday. The company said it intends to use the net proceeds from this offering for working capital and general corporate purposes.

According to data from Benzinga Pro, Azitra's ( AZTR ) stock currently has a float of less than 705,000 shares after the company effected a 1-for-30 reverse stock split on July 1. 

How To Buy AZTR Stock:

By now you're likely curious about how to participate in the market for Anitra – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.

In the the case of Anitra, which is trading at $1.27 as of publishing time, $100 would buy you 78.74 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

AZTR Price Action: According to Benzinga Pro, Azitra ( AZTR ) shares are down 74.8% at $1.25 at the time of publication Wednesday.

Read Also:

Texas Instruments Stock Climbs On Q2 Results, Strong Forward Guidance

Image: Pixabay

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Springworks Therapeutics Insider Sold Shares Worth $801,372, According to a Recent SEC Filing
Springworks Therapeutics Insider Sold Shares Worth $801,372, According to a Recent SEC Filing
Jun 5, 2024
04:13 PM EDT, 06/05/2024 (MT Newswires) -- Badreddin Edris, Chief Operating Officer, on June 03, 2024, sold 20,000 shares in Springworks Therapeutics ( SWTX ) for $801,372. Following the Form 4 filing with the SEC, Edris has control over a total of 249,600 shares of the company, with 249,600 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773427/000110465924068673/xslF345X03/tm2416457-1_4seq1.xml ...
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,115,422, According to a Recent SEC Filing
Regeneron Pharmaceuticals Insider Sold Shares Worth $1,115,422, According to a Recent SEC Filing
Jun 5, 2024
04:13 PM EDT, 06/05/2024 (MT Newswires) -- Marion McCourt, Executive Vice President, Commercial, on June 03, 2024, sold 1,138 shares in Regeneron Pharmaceuticals ( REGN ) for $1,115,422. Following the Form 4 filing with the SEC, McCourt has control over a total of 13,105 shares of the company, with 12,931 shares held directly and 174 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/872589/000196820224000100/xslF345X03/edgardoc.xml...
--ChargePoint Guides For Q2 Revenue of $108-$118 Million, vs CIQ Analyst Consensus of $123 Million
--ChargePoint Guides For Q2 Revenue of $108-$118 Million, vs CIQ Analyst Consensus of $123 Million
Jun 5, 2024
04:13 PM EDT, 06/05/2024 (MT Newswires) -- Price: 1.7700, Change: +0.05, Percent Change: +2.91 ...
Springworks Therapeutics Insider Sold Shares Worth $1,955,113, According to a Recent SEC Filing
Springworks Therapeutics Insider Sold Shares Worth $1,955,113, According to a Recent SEC Filing
Jun 5, 2024
04:12 PM EDT, 06/05/2024 (MT Newswires) -- Saqib Islam, Director, Chief Executive Officer, on June 03, 2024, sold 49,000 shares in Springworks Therapeutics ( SWTX ) for $1,955,113. Following the Form 4 filing with the SEC, Islam has control over a total of 1,112,368 shares of the company, with 1,112,368 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1773427/000110465924068675/xslF345X03/tm2416457-3_4seq1.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved